Daily news

Using evidence as the guiding star, the @ducrest Twitter timeline consists of the latest scientific publications in dermatology, cosmetic dermatology, cosmetics and Home-Use devices. Here you will find interesting information gleaned from science and technology sources as well as the lay press.

« page 213

Innovation in Dermatology and Skin – check out my latest article linkedin.com/pulse/innovati… via @LinkedIn
Sources:…

https://twitter.com/i/web/status/1286355620292157449

12:40pm Jul 23 2020 —

RT @guardian: Researchers unveil test that can detect cancer years before symptoms theguardian.com/science/2020/j…

10:49am Jul 23 2020 —

Starve the Cancer shar.es/abs6IQ via @UCSB #CancerAwareness

10:27am Jul 23 2020 —

@JAADjournals @FreddysillerMD @RoxanaDaneshjou @juleslipoff Bravo 👏🏽

in reply to JAADjournals — 10:24am Jul 23 2020 —

RT @JAADjournals: . @FreddysillerMD @RoxanaDaneshjou and @juleslipoff discuss ways to increase the visibility of the contributions of women…

10:21am Jul 23 2020 —

Nemolizumab (N) is a humanized monoclonal antibody against IL-31 receptor A involved in pruritus & atopic dermatiti…

https://twitter.com/i/web/status/1286240396830531584

in reply to ducrest — 5:03am Jul 23 2020 —

Innovative therapies for skin diseases – #AlmirallShare is looking for partnering opportunities on new assets (e.g.…

https://twitter.com/i/web/status/1286186465098178562

1:28am Jul 23 2020 —

Rilzabrutinib Shows Positive Results in Phase 2b for Pemphigus medscape.com/viewarticle/93… via ⁦@Medscape⁩ #dermatology #dermatologia

11:34pm Jul 22 2020 —

DPP-4 Inhibitors Tied to Blistering Skin Condition medpagetoday.com/dermatology/ge… via ⁦@medpagetoday⁩ #dermatology…

https://twitter.com/i/web/status/1286157449062481926

11:33pm Jul 22 2020 —

RT @SeemalRDesaiMD: Great study on #tacrolimus for #atopicdermatitis. On a different note, I use tacrolimus so frequently off-label for my…

11:12pm Jul 22 2020 —